Comparative effectiveness of empagliflozin versus dapagliflozin in adults with metabolic dysfunction-associated steatotic liver disease.

Front Endocrinol (Lausanne) · 2025 · PMC12554547 · PMID 41158635

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

However, significant interactions were observed for age groups (p for interaction=0.04), and there was a borderline significant interaction for BMI categories (p for interaction=0.06).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.